One in three adults aged 60 and over suffering from a hip fracture dies within one year. Now, a Purdue University-affiliated startup is moving closer to the start of clinical trials for a novel injectable drug that is targeted to heal broken bones faster and strengthen weak bones.
Novosteo, the startup developing the drug, was co-founded by father-son team Philip S. Low, the Presidential Scholar for Drug Discovery and the Ralph C. Corley Distinguished Professor of Chemistry, and Stewart A. Low, the company’s CSO and Visiting Scholar in Purdue’s Department of Chemistry. The treatment was developed in the Purdue laboratory of Low in the Purdue Institute of Drug Discovery. Currently there are 288 clinical trials performed or in process using Purdue-developed medical treatments at 4,841 sites across the globe.
Scott Salka, who recently joined the startup as executive chair, will use his 28 years of experience as a biotechnology entrepreneur to help Novosteo move its innovations from the laboratory to clinical trials and ultimately in to the hands of doctors and patients.
“We have been working on some amazing science with people truly dedicated to making a difference in reducing the mortality and improving the quality of life for our aging population,” said Salka. “We have completed preclinical studies with NOV004 and are looking to take it to clinical trials later this year.”
As CEO, Salka has successfully led efforts to advance novel drugs through preclinical and early clinical development, most recently at publicly traded Ampliphi, now Armata NYSE: ARMP. Prior to that he founded and served as CEO for both Ambit Biosciences, acquired by Daiichi Sankyo OTC: DSNKY, and Rakuten Medical.
Novosteo is already looking at the future use of the injectable-targeted drug for other applications, including dental implants, head and facial fractures, and hip and knee replacements. In addition, Novosteo has a pipeline of drugs for treating an array of musculoskeletal maladies. Salka will present some of the technology at Biocom’s Global Life Science Partnering Conference this month in La Jolla, California.
The Latest Updates from Bing News & Google News
Go deeper with Bing News on:
- Gene therapies close in on a cure for sickle-cell diseaseon August 25, 2021 at 7:21 am
Seventy years ago, sickle-cell disease was at the cutting edge of biomedical research as the first medical condition to be linked to a molecular cause. But the ensuing decades saw little progress in ...
- Magic G Michael Carter-Williams has ankle surgery, will miss start of seasonon August 24, 2021 at 1:39 pm
The Orlando Magic announced Tuesday that veteran guard Michael Carter-Williams will miss the start of the upcoming regular season after undergoing surgery Monday on his left ankle to remove a bone ...
- Electrotherapy Market Size Worth USD 1,463.74 Million by 2027 at 7.1% CAGR - Report by Market Research Future (MRFR)on August 24, 2021 at 11:30 am
Electrotherapy Market Insights and Industry Analysis by Treatment Type (Extracorporeal Shock Wave Therapy, Interferential Current Therapy, Magnetic Field Therapy, Ultrasound Therapy, Transcutaneous ...
- Discovery that TRPV4 gene regulates cartilage growth might yield future therapies for joint repairon August 24, 2021 at 8:08 am
New information from a study reported in Stem Cells might result in more effective treatments for osteoarthritis and other cartilage diseases, as well as hereditary disorders affecting cartilage ...
- In Terms of Glenoid Defects, Does Size Matter?on August 24, 2021 at 5:01 am
The study, “ A glenoid defect of 13.5% or larger is not always critical in male competitive rugby and American football players undergoing arthroscopic bony Bankart repair: Contribution of resultant ...
Go deeper with Google Headlines on:
Go deeper with Bing News on:
- Kiio study highlights how an exercise therapy app can help employers and payers reduce costs associated with low back and other joint painon August 25, 2021 at 4:30 am
Among the large, claims-based study’s findings was a dramatic 62% lower medical spend, 89% lower opioid use, and 51% lower use of antidepressants for Kiio participants.
- Penn State Extension to provide ‘LIFT’ strength-training in Clearfieldon August 25, 2021 at 2:00 am
CLEARFIELD — Penn State Extension will offer an in-person and group-based strength-training program for inactive to moderately active adults ages 40 and older.
- Bone Graft Substitutes Market: High Demand Particularly for Spine Fusion to Drive Global Marketon August 24, 2021 at 7:05 am
Transparency Market Research has published a new report titled, ‘Global Bone Graft Substitutes Market.’ According to the report, the global bone graft substitutes market was valued at US$ 2.9 Bn in ...
- Bone Cements Market Size Report 2027: Segmentation by Region, Types, Application and Major Companies with Coivd-19 Impact Analysison August 23, 2021 at 3:03 am
Aug (The Expresswire) -- "Final Report will add the analysis of the impact of COVID-19 on this industry" “Bone Cements Market” share is projected ...
- The best bone-conduction headphones for sound and safetyon August 23, 2021 at 2:30 am
Headphones can play a lot of valuable roles: they let you jam out to music, dive into podcasts, or dial into phone calls while blocking out environmental noise. This can help you concentrate on tasks, ...